Your browser doesn't support javascript.
Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge.
Herz-Roiphe, R; Kim, A Y; Kaimal, A J; Goldfarb, I T.
  • Herz-Roiphe R; Harvard Medical School, Boston, MA, USA. Electronic address: rachel_herz-roiphe@hms.harvard.edu.
  • Kim AY; Harvard Medical School, Boston, MA, USA; Department of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA.
  • Kaimal AJ; Harvard Medical School, Boston, MA, USA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.
  • Goldfarb IT; Harvard Medical School, Boston, MA, USA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.
J Hosp Infect ; 129: 38-40, 2022 11.
Article in English | MEDLINE | ID: covidwho-2049481

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: J Hosp Infect Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: J Hosp Infect Year: 2022 Document Type: Article